S

Sarah Cannon Research Institute

Community-based oncology clinical research organization

Conflict of Interest Regulatory Coordinator

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeRemote in USANo salary listed

About the Job

Requirements

  • An Associate Degree is required; a Bachelor's Degree is preferred.
  • Regulatory experience is preferred.
  • Customer service experience is preferred.

Responsibilities

  • Process regulatory document signature requests through an electronic signature platform.
  • Work with Regulatory and SCRI Leaders to identify and coordinate Conflict of Interest reporting to Regulatory Agencies throughout the life of a study.
  • Collaborate with the Compliance Team to coordinate Mitigation Plan Strategies and communication for the network.
  • Track documents pending site regulatory signatures.
  • Provide site-level regulatory support to Clinical Operations sites and internal department managers concerning the status of start-up and ongoing regulatory maintenance.
  • Establish and maintain a document management system for regulatory paper and electronic files.

Desired Qualifications

  • Regulatory experience.
  • Customer service experience.

About the Company

Sarah Cannon Research Institute

Community-based oncology clinical research organization

Sarah Cannon Research Institute (SCRI) is a global oncology research organization that conducts cancer clinical trials in community settings, partnering with pharmaceutical and biotech sponsors, physicians, and patients to develop new treatments. It works as an oncology-focused contract research organization (CRO) and centralized site management organization (SMO), running trials across more than 200 locations with roughly 1,500 research physicians, and applies technology such as its Accelero platform to personalized-medicine studies. Over more than 30 years it has completed more than 900 first-in-human trials across early- to late-phase research. What sets SCRI apart is this community-based model paired with early-phase depth, which has helped advance most new cancer therapies the FDA approved in the past decade. The goal is to accelerate oncology research from early trials to approval and bring advanced cancer treatments to patients.

Company size
1-10
Company stage
Not listed
Total funding
Not listed
Headquarters
Beach Haven, NJ
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at Sarah Cannon Research Institute

See more jobs